Name
GlaxoSmithKline (United States)

CoPED ID
08d7f436-c91d-4c5b-a327-a499538f0f13

About


Projects in CoPED

Future Vaccine Manufacturing Hub: Advancing the manufacture and deployment of cost effective vaccines

Status: Closed
Total funding: £62,759,750
From: Dec. 1, 2017
To: Sept. 1, 2023
Organisations: 15
People: 14



People in CoPED

Addresses
GlaxoSmithKline (United States)

19104